necrobiosis

Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

Related to necrobiosis: necrobiosis lipoidica diabeticorum

nec·ro·bi·o·sis

(nĕk′rō-bī-ō′sĭs)

The natural death of cells or tissues through aging, as distinguished from necrosis or pathological death.

nec′ro·bi·ot′ic (-ŏt′ĭk) adj.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

necrobiosis

(ˌnɛkrəʊbaɪˈəʊsɪs)

(Physiology) physiol the normal degeneration and death of cells. Compare necrosis

necrobiotic adj

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ThesaurusAntonymsRelated WordsSynonymsLegend:

Switch to new thesaurus

Noun

necrobiosis - (physiology) the normal degeneration and death of living cells (as in various epithelial cells)

cell death

physiology - the branch of the biological sciences dealing with the functioning of organisms

death - the permanent end of all life functions in an organism or part of an organism; "the animal died a painful death"

apoptosis, caspase-mediated cell death, programmed cell death - a type of cell death in which the cell uses specialized cellular machinery to kill itself; a cell suicide mechanism that enables metazoans to control cell number and eliminate cells that threaten the animal's survival

Translations

nec·ro·bi·o·sis

n. necrobiosis, degeneración gradual de células y tejidos como resultado de cambios debidos al desarrollo, el envejecimiento y el uso.

English-Spanish Medical Dictionary © Farlex 2012

Mentioned in ?

References in periodicals archive ?

M2 EQUITYBITES-October 3, 2018-Processa Pharmaceuticals wins US FDA clearance to start Phase 2 clinical development of PCS-499 in patients with Necrobiosis Lipoidica

Processa Pharmaceuticals wins US FDA clearance to start Phase 2 clinical development of PCS-499 in patients with Necrobiosis Lipoidica

Global Banking News-October 3, 2018-Processa Pharmaceuticals wins US FDA clearance to start Phase 2 clinical development of PCS-499 in patients with Necrobiosis Lipoidica

Processa Pharmaceuticals wins US FDA clearance to start Phase 2 clinical development of PCS-499 in patients with Necrobiosis Lipoidica

M2 PHARMA-October 3, 2018-Processa Pharmaceuticals wins US FDA clearance to start Phase 2 clinical development of PCS-499 in patients with Necrobiosis Lipoidica

Processa Pharmaceuticals wins US FDA clearance to start Phase 2 clinical development of PCS-499 in patients with Necrobiosis Lipoidica

El Kamshoushy et al reported that injection of SD as much as 2% or 20 mg/ml not only caused fat cell necrosis, but also resulted in necrobiosis of the lower dermis tissue adjacent to the subcutaneous fat tissue (19).

Apoptosis of Adipose-Derived Stem Cells Induced by Liposomal Soybean Phosphatidylcholine Extract

Necrobiosis lipoidica###Anytime###Atrophic center###Punch

Skin biopsy-some key concepts and guidelines

Many skin lesions like bullosis diabeticorum and necrobiosis lipoidica have classically been considered specific for DM, though conflicting new shreds of evidence are seen [4-6].

Scleredema Diabeticorum with Superimposed Cellulitis and Abscess Formation

Cutaneous manifestations of diabetes are classified into four categories: Skin lesions with strong-to-weak association to diabetes (necrobiosis lipoidica, diabetic dermopathy, diabetic bullae, yellow skin, eruptive xanthomas, perforating disorders, acanthosis nigricans, oral leucoplakia, lichen planus), infections (bacterial, fungal), cutaneous manifestations of diabetic complications (microangiopathy, macroangiopathy, neuropathy) and skin reactions to diabetic treatment (Sulphonylureas or insulin).

A descriptive study-cutaneous manifestations of diabetes

In addition, sporadic hepatic necrobiosis observed in samples of several AD rabbits was the most severe finding and indicated gradual, less fulminant development of IRI compared with CG and PGE1 animals.

Ischemic preconditioning vs adenosine vs prostaglandin E1 for protection against liver ischemia/reperfusion injury

Differential diagnoses for perineal nodular induration Differential diagnosis Histolopathological features Ischemic fasciitis (13-15) Outer fringe of mitotically active fibroblasts and occasional ganglion-like cells and small vessels surrounding a central zone of necrobiosis Cellular angofibrom (*16) Uniformly moderately cellular with plump, bland spindle cells, hyalinized round, thick and walled vessels may contain adipose tissue Angiomyofibroblastoma-like tumour Alternating hypercellular and of the male genital tract (*17) hypocellular areas with clusters of rounded, epithelioid cells around numerous small vessels Mammary type fibroblastoma (*18) Well-circumscribed, more cellular, and lacks a central zone pattern.

Surgical excision of perineal nodular induration: a cyclist's third testicle

In the model group, there was serious large-area necrobiosis in the ventricular membrane and subendocardial with fibroblastic proliferation and presence of inflammatory cells infiltration.

Targeted metabolomic profiling of cardioprotective effect of Ginkgo biloba L. extract on myocardial ischemia in rats

Pigmentation and dermatosderosis may be mimicked by disorders such as dermatitis, myxoedema, necrobiosis diabeticorum, conditions with increased intra-abdominal pressure, i.e.